← Leaderboards
Amyn Habib
Ut Southwestern Medical Center
$5,683,007
Attributed
$5,683,007
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $818.2K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,683,007 · 5
VA$0 · 1
By mechanism
R01$5,154,887 · 4
K08$528,120 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Hans-Christian Reinecker$19,352,581
- Dayoung Oh$3,399,518
- Rene L Galindo$2,308,569
- William T Dauer$16,076,801
- Amit Singal$17,388,983
Others in their field
Top investigators on “Biological”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologicalPathway InteractionsCellsGliomaMediatingOncogenicSignal TransductionOverexpressionGlioblastomaEpidermal Growth Factor ReceptorResponseResistancePlayMalignant NeoplasmsMutantSignal PathwayEgfr Gene AmplificationMouse ModelEpidermal Growth Factor Receptor ViiiLigandsTumorMutationEffective TherapyReporting
Grant awards (27)
The kinase inhibited RTK forms a scaffold to drive therapeutic resistance in cancer$449,196
R01 · FY2025 · CA · contact PI
Bimodal EGFR signaling in glioblastoma$369,000
R01 · FY2025 · NS · contact PI
Bimodal EGFR signaling in glioblastoma$397,700
R01 · FY2024 · NS · contact PI
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma$356,392
R01 · FY2024 · CA · contact PI
Bimodal EGFR signaling in glioblastoma$413,910
R01 · FY2023 · NS · contact PI
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma$367,647
R01 · FY2023 · CA · contact PI
Bimodal EGFR signaling in glioblastoma$429,910
R01 · FY2022 · NS · contact PI
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma$367,645
R01 · FY2022 · CA · contact PI
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma$377,049
R01 · FY2021 · CA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2021 · VA · contact PI
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma$386,138
R01 · FY2020 · CA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2020 · VA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2019 · VA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2018 · VA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2017 · VA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2016 · VA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2015 · VA · contact PI
Interactions between inflammatory and oncogenic signaling pathways in GBM$0
I01 · FY2014 · VA · contact PI
A Role for RIP1 in Gliomagenesis$307,720
R01 · FY2012 · NS · contact PI
A Role for RIP1 in Gliomagenesis$307,720
R01 · FY2011 · NS · contact PI
A Role for RIP1 in Gliomagenesis$310,860
R01 · FY2010 · NS · contact PI
A Role for RIP1 in Gliomagenesis$314,000
R01 · FY2009 · NS · contact PI
EGFR MEDIATED APOPTOSIS IN GLIOMAS$70,070
K08 · FY2003 · CA
EGFR MEDIATED APOPTOSIS IN GLIOMAS$61,960
K08 · FY2003 · CA
EGFR MEDIATED APOPTOSIS IN GLIOMAS$132,030
K08 · FY2002 · CA
EGFR MEDIATED APOPTOSIS IN GLIOMAS$132,030
K08 · FY2001 · CA
EGFR MEDIATED APOPTOSIS IN GLIOMAS$132,030
K08 · FY2000 · CA